MAPK/ERK kinase inhibitors
US8022057B2 · kind B2 · utility
1Cited by
1References
82Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 7, 2008 |
| Grant date | Sep 20, 2011 |
| Priority date | — |
| Expiry date | Sep 24, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D513/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of the following formula are provided for use with MEK:wherein the variables are as defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds; methods and intermediates useful for making the compounds; and methods of using said compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.